7th annual program overview the 7 annual … · continuing nursing education provider unit, boston...
TRANSCRIPT
5635 Fishers Lane • Suite 6000 • Rockville, MD 20852
March 30-31, 2012, Caesars Palace Hotel, Las Vegas
CHAIRLee S. Schwartzberg, MD, FACPMedical Director, The West Clinic
Jame Abraham, MD, FACPBonnie Wells Wilson Distinguished Professor and Eminent ScholarWest Virginia University
Ted A. Okon, MBAExecutive DirectorCommunity Oncology AllianceWashington, DC
CO-CHAIRSLinda D. Bosserman, MD, FACPPresident, Wilshire Oncology Medical Group, Inc.
David H. Henry, MD, FACPClinical Professor of MedicinePennsylvania Hospital, University of Pennsylvania
March 30-31, 2012Caesars Palace Hotel, Las Vegas
Visit www.globalacademycme.com/oncology for more information and registration
WHO SHOULD ATTEND• Medical oncologists • Hematologists • Radiation oncologists • Oncology nurses • Administrators, and other oncology healthcare professionals.
LEARNING OBJECTIVESAfter participating in this activity, the learner should be better able to:• Discuss how healthcare reform is affecting
oncology care in the United States, including new payment systems.
• Identify issues and potential solutions that prac-tice managers face in day-to-day business.
• Summarize translational theories that sup-port the idea of using molecular and signal-ing pathways in the development of targeted treatments for cancer.
• Detail new developments in the manage-ment of triple-negative and hereditary forms of breast cancer.
• Explain the importance of ensuring ongoing cardiovascular and bone health in cancer sur-vivors.
• Develop individualized treatment approaches for patients with non-small cell lung cancer using tumor genotype and histologic infor-mation.
• Enumerate individualized treatment strate-gies for patients with head and neck cancer.
• Explain how to integrate new agents and treatment strategies into the clinical man-agement of patients with melanoma.
• Summarize recent updates on lymphoma and myeloma from recently held clinical con-ferences.
• Examine advances in clinical and translational cancer research in colorectal, prostate, and pancreatic cancer.
• Identify appropriate criteria for initiation of treatment for chronic lymphocytic leukemia.
• Discuss existing and emerging treatments in multiple myeloma that can be used for patients who have relapsed or recurrent disease.
ACCREDITATION STATEMENTPHYSICIANSThis activity has been planned and implemented in ac-cordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Educa-tion (ACCME) through the joint sponsorship of Boston University School of Medicine and Global Academy for Medical Education. Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their par-ticipation in the activity.
NURSESThis educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and co-provided by Global Academy for Medical Education.Continuing Nursing Education Provider Unit, Boston Uni-versity School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact Hours: 14.75Participants desiring a CNE certifi cate must complete and hand in a Claim for Credit form (indicating sessions attended) and an Evaluation form.
FACULTY DISCLOSUREBoston University School of Medicine asks all individu-als involved in the development and presentation of Continuing Medical Education (CME) activities to dis-close all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent confl icts of interest. In addition, faculty members are asked to disclose when any un-approved use of pharmaceuticals and devices is being discussed.
SPECIAL NEEDSWe encourage participation by all individuals. If you have a disability, advance notifi cation of any special needs will help us better serve you. Please email at least three weeks in advance [email protected].
Visit www.globalacademycme.com/oncology for more information and registration
Jointly sponsored/Co-provided by In affi liation with Also presented byJointly sponsored/Co-provided by In affi liation with Also presented by
PROGRAM OVERVIEWThe 7th Annual Community Oncology Conference is designed to focus on clinical and practical management issues that are a high importance to community-based oncologists and their practice teams.
Taking the “how to” approach, speakers will address specifi c therapies and their implementation in community practice, side effects and their effective manage-ment, and political and fi nancial challenges and ways to navigate them. Clinical ses-sions will provide attendees with the latest developments in treatment strategies. Case-based and interactive discussions provide perspective on what these strategies mean for the oncologist. Benefi t from expert guidance on practice manage-ment and the techniques that will help your practice thrive. Robust panel discussions on the impact of healthcare reform and controversies in patient care will engage and involve you.
Whether your practice is small, medium, or large, the 7th Annual Community Oncology Conference is a valuable resource and forum on the clinical and practical issues that matter to you and your patients. Join us March 30-31 in Las Vegas.
—Lee S. Schwartzberg, MD, FACPChair
7th Annual
Jointly sponsored/Co-provided by In affi liation with Also presented by
7th Annual
Early Bird Discount Available
7th Annual7th Annual
FEATURING
The New Alignment: Collaborative Relationships in Community Oncology
REGISTER NOW
Early Bird Discount Available
7th Annual
REGISTER NOW
Earn CME/CNE credits. Learn how to navigate oncology’s challenging clinical and practice issues.
Community Oncology Alliance
EARN 14.75
CME/CNE CREDITS
Visit www.globalacademycme.com/oncology for more information and registration
EARN 14.75 CME/CNE CREDITS
You’ll get practical and actionable information for physician leaders,nurses and administra-tors—from medicalhomes to hospital andnetwork affi liations.
Clinical & Practice Management Tracks
Clinical & Practice Management Tracks
5635 Fishers Lane • Suite 6000 • Rockville, MD 20852
March 30-31, 2012, Caesars Palace Hotel, Las Vegas
CHAIRLee S. Schwartzberg, MD, FACPMedical Director, The West Clinic
Jame Abraham, MD, FACPBonnie Wells Wilson Distinguished Professor and Eminent ScholarWest Virginia University
Ted A. Okon, MBAExecutive DirectorCommunity Oncology AllianceWashington, DC
CO-CHAIRSLinda D. Bosserman, MD, FACPPresident, Wilshire Oncology Medical Group, Inc.
David H. Henry, MD, FACPClinical Professor of MedicinePennsylvania Hospital, University of Pennsylvania
March 30-31, 2012Caesars Palace Hotel, Las Vegas
Visit www.globalacademycme.com/oncology for more information and registration
WHO SHOULD ATTEND• Medical oncologists • Hematologists • Radiation oncologists • Oncology nurses • Administrators, and other oncology healthcare professionals.
LEARNING OBJECTIVESAfter participating in this activity, the learner should be better able to:• Discuss how healthcare reform is affecting
oncology care in the United States, including new payment systems.
• Identify issues and potential solutions that prac-tice managers face in day-to-day business.
• Summarize translational theories that sup-port the idea of using molecular and signal-ing pathways in the development of targeted treatments for cancer.
• Detail new developments in the manage-ment of triple-negative and hereditary forms of breast cancer.
• Explain the importance of ensuring ongoing cardiovascular and bone health in cancer sur-vivors.
• Develop individualized treatment approaches for patients with non-small cell lung cancer using tumor genotype and histologic infor-mation.
• Enumerate individualized treatment strate-gies for patients with head and neck cancer.
• Explain how to integrate new agents and treatment strategies into the clinical man-agement of patients with melanoma.
• Summarize recent updates on lymphoma and myeloma from recently held clinical con-ferences.
• Examine advances in clinical and translational cancer research in colorectal, prostate, and pancreatic cancer.
• Identify appropriate criteria for initiation of treatment for chronic lymphocytic leukemia.
• Discuss existing and emerging treatments in multiple myeloma that can be used for patients who have relapsed or recurrent disease.
ACCREDITATION STATEMENTPHYSICIANSThis activity has been planned and implemented in ac-cordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Educa-tion (ACCME) through the joint sponsorship of Boston University School of Medicine and Global Academy for Medical Education. Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their par-ticipation in the activity.
NURSESThis educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and co-provided by Global Academy for Medical Education.Continuing Nursing Education Provider Unit, Boston Uni-versity School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact Hours: 14.75Participants desiring a CNE certifi cate must complete and hand in a Claim for Credit form (indicating sessions attended) and an Evaluation form.
FACULTY DISCLOSUREBoston University School of Medicine asks all individu-als involved in the development and presentation of Continuing Medical Education (CME) activities to dis-close all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent confl icts of interest. In addition, faculty members are asked to disclose when any un-approved use of pharmaceuticals and devices is being discussed.
SPECIAL NEEDSWe encourage participation by all individuals. If you have a disability, advance notifi cation of any special needs will help us better serve you. Please email at least three weeks in advance [email protected].
Visit www.globalacademycme.com/oncology for more information and registration
Jointly sponsored/Co-provided by In affi liation with Also presented byJointly sponsored/Co-provided by In affi liation with Also presented by
PROGRAM OVERVIEWThe 7th Annual Community Oncology Conference is designed to focus on clinical and practical management issues that are a high importance to community-based oncologists and their practice teams.
Taking the “how to” approach, speakers will address specifi c therapies and their implementation in community practice, side effects and their effective manage-ment, and political and fi nancial challenges and ways to navigate them. Clinical ses-sions will provide attendees with the latest developments in treatment strategies. Case-based and interactive discussions provide perspective on what these strategies mean for the oncologist. Benefi t from expert guidance on practice manage-ment and the techniques that will help your practice thrive. Robust panel discussions on the impact of healthcare reform and controversies in patient care will engage and involve you.
Whether your practice is small, medium, or large, the 7th Annual Community Oncology Conference is a valuable resource and forum on the clinical and practical issues that matter to you and your patients. Join us March 30-31 in Las Vegas.
—Lee S. Schwartzberg, MD, FACPChair
7th Annual
Jointly sponsored/Co-provided by In affi liation with Also presented by
7th Annual
Early Bird Discount Available
7th Annual7th Annual
FEATURING
The New Alignment: Collaborative Relationships in Community Oncology
REGISTER NOW
Early Bird Discount Available
7th Annual
REGISTER NOW
Earn CME/CNE credits. Learn how to navigate oncology’s challenging clinical and practice issues.
Community Oncology Alliance
EARN 14.75
CME/CNE CREDTIS
Visit www.globalacademycme.com/oncology for more information and registration
EARN 14.75 CME/CNE CREDTIS
You’ll get practical and actionable information for physician leaders,nurses and administra-tors—from medicalhomes to hospital andnetwork affi liations.
Clinical & Practice Management Tracks
Clinical & Practice Management Tracks
FR
IDA
Y,
MA
RC
H 3
0,
20
12
6:30 am Registration, Continental Breakfast and Visit Exhibits
7:30 am
CLI
NIC
AL
TR
AC
K
What Matters: Targeted Therapies and the Community OncologistLee S. Schwartzberg, MD
7:45 am PLENARY: On the Therapeutic Horizon — The Next Targeted TherapiesHoward A. Burris III, MD
8:30 am Breast Cancer: 2012 UpdateLee S. Schwartzberg, MD
9:00 am Prostate Cancer: Developments and TreatmentsJudd W. Moul, MD
9:30 am Interactive Panel Discussion
10:00 am BREAK AND VISIT EXHIBITS
10:30 am Lung Cancer: EGFR Inhibitors and the Future of Targeted TherapiesCorey J. Langer, MD
11:00 am Targeted Therapies for Colon CancerRandy Hecht, MD
11:30 am The Best of Community Translations: Year in ReviewJame Abraham, MD
12:00 pm Interactive Panel Discussion
12:30 pm BREAK/PICK UP LUNCHES IN EXHIBIT HALL
12:45 pm
PR
AC
TIC
E M
AN
AG
EM
EN
T
TR
AC
K
Luncheon Debate: Impact of the Affordable Care Act (ACA) of 2010 on Oncology Practice
Ted A. Okon, MBA, Allen S. Lichter, MD, Christian Downs, MHA, JD, Matthew E. Brow
1:45 pm The New Alignment: Collaborative Relationships in Community Oncology
Leonard Kalman, MD, Linda D. Bosserman, MD, David H. Henry, MD, Lee S. Schwartzberg, MD, Steven G. Roshon, MD
3:00 pm Structures of CollaborationsMichael L. Blau, JD
3:30 pm BREAK AND VISIT EXHIBITS
3:45 pm Oncology Medical Home — Levels of PracticeRobert Gamble, Bruce J. Gould, MD
4:30 pm Interactive Panel Discussion
5:10 pm Networking Reception in Exhibit Hall with Guest Speaker
SA
TU
RD
AY
, M
AR
CH
31
, 2
01
2
7:00 am Continental Breakfast and Visit Exhibits
7:55 am
CLI
NIC
AL
TR
AC
K
Welcome
8:00 am PLENARY: The Future of Treatment for MyelomaJames R. Berenson, MD
8:45 am Clinical Developments in Chronic Lymphocytic Leukemia Steven Coutre, MD
9:15 am New Targets and Pathways in Head and Neck CancerEzra Cohen, MD
9:45 am Patient Survivor Care: Maintaining Bone HealthG. David Roodman, MD, PhD
10:15 am BREAK AND VISIT EXHIBITS
10:45 am
CLI
NIC
AL
TR
AC
K
Metastatic Melanoma: Best Practices for the Use of Novel Therapies
Vernon K. Sondak, MD
Reimbursement Program Landscape 2012
Roberta L. Buell, MBA
PR
AC
TIC
E M
AN
AG
EM
EN
T T
RA
CK
11:15 am Clinical Conundrums: Case SessionDavid H. Henry, MD, Jame Abraham, MD
New Patient Portal and MoreNancy Davenport-Ennis,
Gwen Mayes, JD, MMSc, Carey Waldrip
12:30 pm LUNCH BREAK
1:30 pm Lymphoma in 2012J. Mark Sloan, MD
Drivers of Change Impacting Patient AccessDenise K. Pierce
2:00 pm Clinical Update on Pancreatic CancerChristopher H. Crane, MD
Oncology Advocacy and MediaScott Parker, Glenn Balasky,
Patti Garner, Carreen F. Huffman
2:30 pm National Committee for Quality Assurance Accreditation and the Medical HomeMargaret O’Kane
3:15 pm Closing Keynote: What’s Ahead for the Community Oncology PracticeLee S. Schwartzberg, MD, and Ted A. Okon, MBA
AGENDA Faculty and sessions subject change. FACULTY CONFERENCE REGISTRATION
Visit www.globalacademycme.com/oncology for faculty, program updates and registration
CONFERENCE CHAIRLee S. Schwartzberg, MD, FACP*The West ClinicMemphis, TN
CO-CHAIRSJame Abraham, MD* †
West Virginia UniversityMorgantown, WV
Linda D. Bosserman, MD* †
Wilshire OncologyMedical Group, Inc.La Verne, CA
David H. Henry, MD* †
Pennsylvania Hospital, University of PennsylvaniaPhiladelphia, PA
Ted A. Okon, MBA*Community Oncology AllianceWashington, DC
CLINICAL FACULTYDebra L. Barton, RN, PhDMayo ClinicRochester, MNDesignated Nurse Planner; not presenting
James R. Berenson, MDInstitute for Myeloma and Bone Cancer ResearchWest Hollywood, CA
Howard A. Burris III, MDSarah Cannon Research InstituteNashville, TN
Ezra Cohen, MDUniversity of ChicagoChicago, IL
Steven Coutre, MD Stanford University Medical SchoolStanford, CA
Christopher H. Crane, MDUniversity of Texas MD Anderson Cancer CenterHouston, TX
Randy Hecht, MDUniversity of California Los Angeles School of Medicine
Corey J. Langer, MDUniversity of PennsylvaniaPhiladelphia, PA
Judd W. Moul, MDDuke University Medical CenterDurham, NC
G. David Roodman, MD, PhDIndiana UniversityIndianapolis, IN
J. Mark Sloan, MD*Boston University School of MedicineBoston, MA
Vernon K. Sondak, MDH. Lee Moffi t Cancer Center and Research InstituteTampa, FL
PRACTICE MANAGEMENT FACULTYGlenn BalaskyThe Mark H. Zangmeister CenterColumbus, OH
Michael L. Blau, JDFoley & Lardner LLPBoston, MA
Matthew E. BrowMcKesson Specialty HealthWashington, DC
Roberta L. Buell, MBAonPoint Oncology, LLCSausalito, CA
Christian Downs, MHA, JDAssociation of Community Cancer CentersWashington, DC
Nancy Davenport-EnnisNational Patient Advocate FoundationNewport News, VA
Robert GambleCommunity Oncology AllianceWashington, DC
Patti GarnerTennessee OncologyNashville, TN
Bruce J. Gould, MDNorthwest Georgia Oncology Centers, PCJasper, GA
Carreen F. HuffmanThe Center for Cancer & Blood DisordersFort Worth, Tx
Leonard Kalman, MDAdvanced Medical SpecialtiesMiami, FL
Allen S. Lichter, MDAmerican Society of Clinical OncologyAlexandria, VA
Gwen Mayes, JD, MMScNational Patient Advocate FoundationNewport News, VA
Margaret E. O’KaneNational Committee for Quality AssuranceWashington, DC
Scott ParkerNorthwest Georgia Oncology Centers, PCJasper, GA
Denise K. PierceDK Pierce and Associates, Inc.Zionsville, IN
Steven G. Roshon, MD Cleveland Clinic Cancer CentersClyde, OH
Carey WaldripPrescription Access Point at National Patient Advocate FoundationNewport News, VA
*Conference Planning Committee† Community Oncology Editorial Board
Register online—It’s fast, easy, and reliable www.globalacademycme.com/oncology
Registration Fees Before 2/15/12 After 2/15/12
Physician $375 $475
Resident, fellow, physician assistant, nurse, nurse practitioner, pharmacist $250 $395
Practice Manager/Administrator $250 $375
Community Oncology Alliance member $175 $275
Industry, not exhibiting $800 $900
CPAN attendee $75 $75
*Guest Pass (must be a guest of registrant; No admittance to sessions) $75 $75
TERMS AND CONDITIONSThe registration fee covers attendance at the meeting, coffee breaks, and exhibits. Reg-istrants please note that photos will be taken of meeting activities and attendance at the meeting gives Global Academy for Medical Education (Global) permission to use the like-ness of individuals capture in these photo, and images on Global Web Sites and promotional materials—faces will not be clearly visible unless permission is granted. Your registration also permits Global to list your name in conference materials. *Guests are not allowed into sessions. The guest fee covers continental breakfast, breaks, and exhibit hall.Exhibitors/Industry must contact Devin Gregorie, [email protected], or at 516.381.8613 for registration instructions.
CANCELLATION POLICYRegistrants who do not cancel according to the following guidelines will forfeit all registration fees. You must write, e-mail, or fax your cancellation request. There is a registration cancel-lation fee of 25% of your registration rate for cancellations received 90 days (12/31/2011) prior to the event. There is a registration cancellation fee of 50% of your registration rate for cancellations received 60 days (01/30/2012) prior to the event. There are no refunds for cancel-lations after 30 days (02/29/2012) prior to the event. “No shows” are not eligible for refunds. Registration refunds will be processed within 60 days of the meeting. Global Academy for Medical Education is not responsible for nonrefundable, nontransferable airline tickets or hotel accommodations purchased for attendance at this course. The participant registration fee cov-ers attendance to the scientifi c meeting, continental breakfasts, coffee breaks and exhibits.
HOTEL ACCOMODATIONSCaesars Palace Hotel3570 Las Vegas Blvd SLas Vegas, Nevada 891091-866-227-5944
A special room rate has been arranged for the Seventh Annual Community Oncology Conference: Single/double: $169 plus applicable taxes. You must book on or before Tuesday, March 13, 2012 to receive this rate. Reservation requests received after the cutoff date will be based upon availability at the hotel’s prevailing rates
Online Hotel Reservationshttps://resweb.passkey.com/go/SCCOC2
Attendees may call the Contact Center at 866-227-5944 to book their reservations. The name of the group is listed as 7th An Com Oncology Conf. Callers can also use your group code to identify the group, SCCOC2.
Jointly sponsored/Co-provided by In affi liation with
Also presented by
Community Oncology Alliance Patient Advocacy Network (CPAN)The Community Oncology Alliance Patient Advocacy Network program (CPAN) will run parallel to the 7th Annual Community Oncology Confer-ence. Multiple symposium sessions will provide attendees with educa-
tion in a variety of oncology issues. A sampling of sessions: Patient Advocacy, Legislative Issues Affecting Patient Care, Health Care Reform Issues Relevant to Cancer Patients and their Care Providers, Oncology Drug Shortages, An In-troduction to Accountable Care Organizations and Medical Homes. Additionally, conference attendees will have informal opportunities to network with fellow advocates, nurses, oncologists, and practice administrators.
To register a patient for the CPAN program, go to www.globalacademycme.com/oncology
FR
IDA
Y,
MA
RC
H 3
0,
20
12
6:30 am Registration, Continental Breakfast and Visit Exhibits
7:30 am
CLI
NIC
AL
TR
AC
K
What Matters: Targeted Therapies and the Community OncologistLee S. Schwartzberg, MD
7:45 am PLENARY: On the Therapeutic Horizon — The Next Targeted TherapiesHoward A. Burris III, MD
8:30 am Breast Cancer: 2012 UpdateLee S. Schwartzberg, MD
9:00 am Prostate Cancer: Developments and TreatmentsJudd W. Moul, MD
9:30 am Interactive Panel Discussion
10:00 am BREAK AND VISIT EXHIBITS
10:30 am Lung Cancer: EGFR Inhibitors and the Future of Targeted TherapiesCorey J. Langer, MD
11:00 am Targeted Therapies for Colon CancerRandy Hecht, MD
11:30 am The Best of Community Translations: Year in ReviewJame Abraham, MD
12:00 pm Interactive Panel Discussion
12:30 pm BREAK/PICK UP LUNCHES IN EXHIBIT HALL
12:45 pm
PR
AC
TIC
E M
AN
AG
EM
EN
T
TR
AC
K
Luncheon Debate: Impact of the Affordable Care Act (ACA) of 2010 on Oncology Practice
Ted A. Okon, MBA, Allen S. Lichter, MD, Christian Downs, MHA, JD, Matthew E. Brow
1:45 pm The New Alignment: Collaborative Relationships in Community Oncology
Leonard Kalman, MD, Linda D. Bosserman, MD, David H. Henry, MD, Lee S. Schwartzberg, MD, Steven G. Roshon, MD
3:00 pm Structures of CollaborationsMichael L. Blau, JD
3:30 pm BREAK AND VISIT EXHIBITS
3:45 pm Oncology Medical Home — Levels of PracticeRobert Gamble, Bruce J. Gould, MD
4:30 pm Interactive Panel Discussion
5:10 pm Networking Reception in Exhibit Hall with Guest Speaker
SA
TU
RD
AY
, M
AR
CH
31
, 2
01
2
7:00 am Continental Breakfast and Visit Exhibits
7:55 am
CLI
NIC
AL
TR
AC
K
Welcome
8:00 am PLENARY: The Future of Treatment for MyelomaJames R. Berenson, MD
8:45 am Clinical Developments in Chronic Lymphocytic Leukemia Steven Coutre, MD
9:15 am New Targets and Pathways in Head and Neck CancerEzra Cohen, MD
9:45 am Patient Survivor Care: Maintaining Bone HealthG. David Roodman, MD, PhD
10:15 am BREAK AND VISIT EXHIBITS
10:45 am
CLI
NIC
AL
TR
AC
K
Metastatic Melanoma: Best Practices for the Use of Novel Therapies
Vernon K. Sondak, MD
Reimbursement Program Landscape 2012
Roberta L. Buell, MBA
PR
AC
TIC
E M
AN
AG
EM
EN
T T
RA
CK
11:15 am Clinical Conundrums: Case SessionDavid H. Henry, MD, Jame Abraham, MD
New Patient Portal and MoreNancy Davenport-Ennis,
Gwen Mayes, JD, MMSc, Carey Waldrip
12:30 pm LUNCH BREAK
1:30 pm Lymphoma in 2012J. Mark Sloan, MD
Drivers of Change Impacting Patient AccessDenise K. Pierce
2:00 pm Clinical Update on Pancreatic CancerChristopher H. Crane, MD
Oncology Advocacy and MediaScott Parker, Glenn Balasky,
Patti Garner, Carreen F. Huffman
2:30 pm National Committee for Quality Assurance Accreditation and the Medical HomeMargaret O’Kane
3:15 pm Closing Keynote: What’s Ahead for the Community Oncology PracticeLee S. Schwartzberg, MD, and Ted A. Okon, MBA
AGENDA Faculty and sessions subject change. FACULTY CONFERENCE REGISTRATION
Visit www.globalacademycme.com/oncology for faculty, program updates and registration
CONFERENCE CHAIRLee S. Schwartzberg, MD, FACP*The West ClinicMemphis, TN
CO-CHAIRSJame Abraham, MD* †
West Virginia UniversityMorgantown, WV
Linda D. Bosserman, MD* †
Wilshire OncologyMedical Group, Inc.La Verne, CA
David H. Henry, MD* †
Pennsylvania Hospital, University of PennsylvaniaPhiladelphia, PA
Ted A. Okon, MBA*Community Oncology AllianceWashington, DC
CLINICAL FACULTYDebra L. Barton, RN, PhDMayo ClinicRochester, MNDesignated Nurse Planner; not presenting
James R. Berenson, MDInstitute for Myeloma and Bone Cancer ResearchWest Hollywood, CA
Howard A. Burris III, MDSarah Cannon Research InstituteNashville, TN
Ezra Cohen, MDUniversity of ChicagoChicago, IL
Steven Coutre, MD Stanford University Medical SchoolStanford, CA
Christopher H. Crane, MDUniversity of Texas MD Anderson Cancer CenterHouston, TX
Randy Hecht, MDUniversity of California Los Angeles School of Medicine
Corey J. Langer, MDUniversity of PennsylvaniaPhiladelphia, PA
Judd W. Moul, MDDuke University Medical CenterDurham, NC
G. David Roodman, MD, PhDIndiana UniversityIndianapolis, IN
J. Mark Sloan, MD*Boston University School of MedicineBoston, MA
Vernon K. Sondak, MDH. Lee Moffi t Cancer Center and Research InstituteTampa, FL
PRACTICE MANAGEMENT FACULTYGlenn BalaskyThe Mark H. Zangmeister CenterColumbus, OH
Michael L. Blau, JDFoley & Lardner LLPBoston, MA
Matthew E. BrowMcKesson Specialty HealthWashington, DC
Roberta L. Buell, MBAonPoint Oncology, LLCSausalito, CA
Christian Downs, MHA, JDAssociation of Community Cancer CentersWashington, DC
Nancy Davenport-EnnisNational Patient Advocate FoundationNewport News, VA
Robert GambleCommunity Oncology AllianceWashington, DC
Patti GarnerTennessee OncologyNashville, TN
Bruce J. Gould, MDNorthwest Georgia Oncology Centers, PCJasper, GA
Carreen F. HuffmanThe Center for Cancer & Blood DisordersFort Worth, Tx
Leonard Kalman, MDAdvanced Medical SpecialtiesMiami, FL
Allen S. Lichter, MDAmerican Society of Clinical OncologyAlexandria, VA
Gwen Mayes, JD, MMScNational Patient Advocate FoundationNewport News, VA
Margaret E. O’KaneNational Committee for Quality AssuranceWashington, DC
Scott ParkerNorthwest Georgia Oncology Centers, PCJasper, GA
Denise K. PierceDK Pierce and Associates, Inc.Zionsville, IN
Steven G. Roshon, MD Cleveland Clinic Cancer CentersClyde, OH
Carey WaldripPrescription Access Point at National Patient Advocate FoundationNewport News, VA
*Conference Planning Committee† Community Oncology Editorial Board
Register online—It’s fast, easy, and reliable www.globalacademycme.com/oncology
Registration Fees Before 2/15/12 After 2/15/12
Physician $375 $475
Resident, fellow, physician assistant, nurse, nurse practitioner, pharmacist $250 $395
Practice Manager/Administrator $250 $375
Community Oncology Alliance member $175 $275
Industry, not exhibiting $800 $900
CPAN attendee $75 $75
*Guest Pass (must be a guest of registrant; No admittance to sessions) $75 $75
TERMS AND CONDITIONSThe registration fee covers attendance at the meeting, coffee breaks, and exhibits. Reg-istrants please note that photos will be taken of meeting activities and attendance at the meeting gives Global Academy for Medical Education (Global) permission to use the like-ness of individuals capture in these photo, and images on Global Web Sites and promotional materials—faces will not be clearly visible unless permission is granted. Your registration also permits Global to list your name in conference materials. *Guests are not allowed into sessions. The guest fee covers continental breakfast, breaks, and exhibit hall.Exhibitors/Industry must contact Devin Gregorie, [email protected], or at 516.381.8613 for registration instructions.
CANCELLATION POLICYRegistrants who do not cancel according to the following guidelines will forfeit all registration fees. You must write, e-mail, or fax your cancellation request. There is a registration cancel-lation fee of 25% of your registration rate for cancellations received 90 days (12/31/2011) prior to the event. There is a registration cancellation fee of 50% of your registration rate for cancellations received 60 days (01/30/2012) prior to the event. There are no refunds for cancel-lations after 30 days (02/29/2012) prior to the event. “No shows” are not eligible for refunds. Registration refunds will be processed within 60 days of the meeting. Global Academy for Medical Education is not responsible for nonrefundable, nontransferable airline tickets or hotel accommodations purchased for attendance at this course. The participant registration fee cov-ers attendance to the scientifi c meeting, continental breakfasts, coffee breaks and exhibits.
HOTEL ACCOMODATIONSCaesars Palace Hotel3570 Las Vegas Blvd SLas Vegas, Nevada 891091-866-227-5944
A special room rate has been arranged for the Seventh Annual Community Oncology Conference: Single/double: $169 plus applicable taxes. You must book on or before Tuesday, March 13, 2012 to receive this rate. Reservation requests received after the cutoff date will be based upon availability at the hotel’s prevailing rates
Online Hotel Reservationshttps://resweb.passkey.com/go/SCCOC2
Attendees may call the Contact Center at 866-227-5944 to book their reservations. The name of the group is listed as 7th An Com Oncology Conf. Callers can also use your group code to identify the group, SCCOC2.
Jointly sponsored/Co-provided by In affi liation with
Also presented by
Community Oncology Alliance Patient Advocacy Network (CPAN)The Community Oncology Alliance Patient Advocacy Network program (CPAN) will run parallel to the 7th Annual Community Oncology Confer-ence. Multiple symposium sessions will provide attendees with educa-
tion in a variety of oncology issues. A sampling of sessions: Patient Advocacy, Legislative Issues Affecting Patient Care, Health Care Reform Issues Relevant to Cancer Patients and their Care Providers, Oncology Drug Shortages, An In-troduction to Accountable Care Organizations and Medical Homes. Additionally, conference attendees will have informal opportunities to network with fellow advocates, nurses, oncologists, and practice administrators.
To register a patient for the CPAN program, go to www.globalacademycme.com/oncology
FR
IDA
Y,
MA
RC
H 3
0,
20
12
6:30 am Registration, Continental Breakfast and Visit Exhibits
7:30 am
CLI
NIC
AL
TR
AC
K
What Matters: Targeted Therapies and the Community OncologistLee S. Schwartzberg, MD
7:45 am PLENARY: On the Therapeutic Horizon — The Next Targeted TherapiesHoward A. Burris III, MD
8:30 am Breast Cancer: 2012 UpdateLee S. Schwartzberg, MD
9:00 am Prostate Cancer: Developments and TreatmentsJudd W. Moul, MD
9:30 am Interactive Panel Discussion
10:00 am BREAK AND VISIT EXHIBITS
10:30 am Lung Cancer: EGFR Inhibitors and the Future of Targeted TherapiesCorey J. Langer, MD
11:00 am Targeted Therapies for Colon CancerRandy Hecht, MD
11:30 am The Best of Community Translations: Year in ReviewJame Abraham, MD
12:00 pm Interactive Panel Discussion
12:30 pm BREAK/PICK UP LUNCHES IN EXHIBIT HALL
12:45 pm
PR
AC
TIC
E M
AN
AG
EM
EN
T
TR
AC
K
Luncheon Debate: Impact of the Affordable Care Act (ACA) of 2010 on Oncology Practice
Ted A. Okon, MBA, Allen S. Lichter, MD, Christian Downs, MHA, JD, Matthew E. Brow
1:45 pm The New Alignment: Collaborative Relationships in Community Oncology
Leonard Kalman, MD, Linda D. Bosserman, MD, David H. Henry, MD, Lee S. Schwartzberg, MD, Steven G. Roshon, MD
3:00 pm Structures of CollaborationsMichael L. Blau, JD
3:30 pm BREAK AND VISIT EXHIBITS
3:45 pm Oncology Medical Home — Levels of PracticeRobert Gamble, Bruce J. Gould, MD
4:30 pm Interactive Panel Discussion
5:10 pm Networking Reception in Exhibit Hall with Guest Speaker
SA
TU
RD
AY
, M
AR
CH
31
, 2
01
2
7:00 am Continental Breakfast and Visit Exhibits
7:55 am
CLI
NIC
AL
TR
AC
K
Welcome
8:00 am PLENARY: The Future of Treatment for MyelomaJames R. Berenson, MD
8:45 am Clinical Developments in Chronic Lymphocytic Leukemia Steven Coutre, MD
9:15 am New Targets and Pathways in Head and Neck CancerEzra Cohen, MD
9:45 am Patient Survivor Care: Maintaining Bone HealthG. David Roodman, MD, PhD
10:15 am BREAK AND VISIT EXHIBITS
10:45 am
CLI
NIC
AL
TR
AC
K
Metastatic Melanoma: Best Practices for the Use of Novel Therapies
Vernon K. Sondak, MD
Reimbursement Program Landscape 2012
Roberta L. Buell, MBA
PR
AC
TIC
E M
AN
AG
EM
EN
T T
RA
CK
11:15 am Clinical Conundrums: Case SessionDavid H. Henry, MD, Jame Abraham, MD
New Patient Portal and MoreNancy Davenport-Ennis,
Gwen Mayes, JD, MMSc, Carey Waldrip
12:30 pm LUNCH BREAK
1:30 pm Lymphoma in 2012J. Mark Sloan, MD
Drivers of Change Impacting Patient AccessDenise K. Pierce
2:00 pm Clinical Update on Pancreatic CancerChristopher H. Crane, MD
Oncology Advocacy and MediaScott Parker, Glenn Balasky,
Patti Garner, Carreen F. Huffman
2:30 pm National Committee for Quality Assurance Accreditation and the Medical HomeMargaret O’Kane
3:15 pm Closing Keynote: What’s Ahead for the Community Oncology PracticeLee S. Schwartzberg, MD, and Ted A. Okon, MBA
AGENDA Faculty and sessions subject change. FACULTY CONFERENCE REGISTRATION
Visit www.globalacademycme.com/oncology for faculty, program updates and registration
CONFERENCE CHAIRLee S. Schwartzberg, MD, FACP*The West ClinicMemphis, TN
CO-CHAIRSJame Abraham, MD* †
West Virginia UniversityMorgantown, WV
Linda D. Bosserman, MD* †
Wilshire OncologyMedical Group, Inc.La Verne, CA
David H. Henry, MD* †
Pennsylvania Hospital, University of PennsylvaniaPhiladelphia, PA
Ted A. Okon, MBA*Community Oncology AllianceWashington, DC
CLINICAL FACULTYDebra L. Barton, RN, PhDMayo ClinicRochester, MNDesignated Nurse Planner; not presenting
James R. Berenson, MDInstitute for Myeloma and Bone Cancer ResearchWest Hollywood, CA
Howard A. Burris III, MDSarah Cannon Research InstituteNashville, TN
Ezra Cohen, MDUniversity of ChicagoChicago, IL
Steven Coutre, MD Stanford University Medical SchoolStanford, CA
Christopher H. Crane, MDUniversity of Texas MD Anderson Cancer CenterHouston, TX
Randy Hecht, MDUniversity of California Los Angeles School of Medicine
Corey J. Langer, MDUniversity of PennsylvaniaPhiladelphia, PA
Judd W. Moul, MDDuke University Medical CenterDurham, NC
G. David Roodman, MD, PhDIndiana UniversityIndianapolis, IN
J. Mark Sloan, MD*Boston University School of MedicineBoston, MA
Vernon K. Sondak, MDH. Lee Moffi t Cancer Center and Research InstituteTampa, FL
PRACTICE MANAGEMENT FACULTYGlenn BalaskyThe Mark H. Zangmeister CenterColumbus, OH
Michael L. Blau, JDFoley & Lardner LLPBoston, MA
Matthew E. BrowMcKesson Specialty HealthWashington, DC
Roberta L. Buell, MBAonPoint Oncology, LLCSausalito, CA
Christian Downs, MHA, JDAssociation of Community Cancer CentersWashington, DC
Nancy Davenport-EnnisNational Patient Advocate FoundationNewport News, VA
Robert GambleCommunity Oncology AllianceWashington, DC
Patti GarnerTennessee OncologyNashville, TN
Bruce J. Gould, MDNorthwest Georgia Oncology Centers, PCJasper, GA
Carreen F. HuffmanThe Center for Cancer & Blood DisordersFort Worth, Tx
Leonard Kalman, MDAdvanced Medical SpecialtiesMiami, FL
Allen S. Lichter, MDAmerican Society of Clinical OncologyAlexandria, VA
Gwen Mayes, JD, MMScNational Patient Advocate FoundationNewport News, VA
Margaret E. O’KaneNational Committee for Quality AssuranceWashington, DC
Scott ParkerNorthwest Georgia Oncology Centers, PCJasper, GA
Denise K. PierceDK Pierce and Associates, Inc.Zionsville, IN
Steven G. Roshon, MD Cleveland Clinic Cancer CentersClyde, OH
Carey WaldripPrescription Access Point at National Patient Advocate FoundationNewport News, VA
*Conference Planning Committee† Community Oncology Editorial Board
Register online—It’s fast, easy, and reliable www.globalacademycme.com/oncology
Registration Fees Before 2/15/12 After 2/15/12
Physician $375 $475
Resident, fellow, physician assistant, nurse, nurse practitioner, pharmacist $250 $395
Practice Manager/Administrator $250 $375
Community Oncology Alliance member $175 $275
Industry, not exhibiting $800 $900
CPAN attendee $75 $75
*Guest Pass (must be a guest of registrant; No admittance to sessions) $75 $75
TERMS AND CONDITIONSThe registration fee covers attendance at the meeting, coffee breaks, and exhibits. Reg-istrants please note that photos will be taken of meeting activities and attendance at the meeting gives Global Academy for Medical Education (Global) permission to use the like-ness of individuals capture in these photo, and images on Global Web Sites and promotional materials—faces will not be clearly visible unless permission is granted. Your registration also permits Global to list your name in conference materials. *Guests are not allowed into sessions. The guest fee covers continental breakfast, breaks, and exhibit hall.Exhibitors/Industry must contact Devin Gregorie, [email protected], or at 516.381.8613 for registration instructions.
CANCELLATION POLICYRegistrants who do not cancel according to the following guidelines will forfeit all registration fees. You must write, e-mail, or fax your cancellation request. There is a registration cancel-lation fee of 25% of your registration rate for cancellations received 90 days (12/31/2011) prior to the event. There is a registration cancellation fee of 50% of your registration rate for cancellations received 60 days (01/30/2012) prior to the event. There are no refunds for cancel-lations after 30 days (02/29/2012) prior to the event. “No shows” are not eligible for refunds. Registration refunds will be processed within 60 days of the meeting. Global Academy for Medical Education is not responsible for nonrefundable, nontransferable airline tickets or hotel accommodations purchased for attendance at this course. The participant registration fee cov-ers attendance to the scientifi c meeting, continental breakfasts, coffee breaks and exhibits.
HOTEL ACCOMODATIONSCaesars Palace Hotel3570 Las Vegas Blvd SLas Vegas, Nevada 891091-866-227-5944
A special room rate has been arranged for the Seventh Annual Community Oncology Conference: Single/double: $169 plus applicable taxes. You must book on or before Tuesday, March 13, 2012 to receive this rate. Reservation requests received after the cutoff date will be based upon availability at the hotel’s prevailing rates
Online Hotel Reservationshttps://resweb.passkey.com/go/SCCOC2
Attendees may call the Contact Center at 866-227-5944 to book their reservations. The name of the group is listed as 7th An Com Oncology Conf. Callers can also use your group code to identify the group, SCCOC2.
Jointly sponsored/Co-provided by In affi liation with
Also presented by
Community Oncology Alliance Patient Advocacy Network (CPAN)The Community Oncology Alliance Patient Advocacy Network program (CPAN) will run parallel to the 7th Annual Community Oncology Confer-ence. Multiple symposium sessions will provide attendees with educa-
tion in a variety of oncology issues. A sampling of sessions: Patient Advocacy, Legislative Issues Affecting Patient Care, Health Care Reform Issues Relevant to Cancer Patients and their Care Providers, Oncology Drug Shortages, An In-troduction to Accountable Care Organizations and Medical Homes. Additionally, conference attendees will have informal opportunities to network with fellow advocates, nurses, oncologists, and practice administrators.
To register a patient for the CPAN program, go to www.globalacademycme.com/oncology
5635 Fishers Lane • Suite 6000 • Rockville, MD 20852
March 30-31, 2012, Caesars Palace Hotel, Las Vegas
CHAIRLee S. Schwartzberg, MD, FACPMedical Director, The West Clinic
Jame Abraham, MD, FACPBonnie Wells Wilson Distinguished Professor and Eminent ScholarWest Virginia University
Ted A. Okon, MBAExecutive DirectorCommunity Oncology AllianceWashington, DC
CO-CHAIRSLinda D. Bosserman, MD, FACPPresident, Wilshire Oncology Medical Group, Inc.
David H. Henry, MD, FACPClinical Professor of MedicinePennsylvania Hospital, University of Pennsylvania
March 30-31, 2012Caesars Palace Hotel, Las Vegas
Visit www.globalacademycme.com/oncology for more information and registration
WHO SHOULD ATTEND• Medical oncologists • Hematologists • Radiation oncologists • Oncology nurses • Administrators, and other oncology healthcare professionals.
LEARNING OBJECTIVESAfter participating in this activity, the learner should be better able to:• Discuss how healthcare reform is affecting
oncology care in the United States, including new payment systems.
• Identify issues and potential solutions that prac-tice managers face in day-to-day business.
• Summarize translational theories that sup-port the idea of using molecular and signal-ing pathways in the development of targeted treatments for cancer.
• Detail new developments in the manage-ment of triple-negative and hereditary forms of breast cancer.
• Explain the importance of ensuring ongoing cardiovascular and bone health in cancer sur-vivors.
• Develop individualized treatment approaches for patients with non-small cell lung cancer using tumor genotype and histologic infor-mation.
• Enumerate individualized treatment strate-gies for patients with head and neck cancer.
• Explain how to integrate new agents and treatment strategies into the clinical man-agement of patients with melanoma.
• Summarize recent updates on lymphoma and myeloma from recently held clinical con-ferences.
• Examine advances in clinical and translational cancer research in colorectal, prostate, and pancreatic cancer.
• Identify appropriate criteria for initiation of treatment for chronic lymphocytic leukemia.
• Discuss existing and emerging treatments in multiple myeloma that can be used for patients who have relapsed or recurrent disease.
ACCREDITATION STATEMENTPHYSICIANSThis activity has been planned and implemented in ac-cordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Educa-tion (ACCME) through the joint sponsorship of Boston University School of Medicine and Global Academy for Medical Education. Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their par-ticipation in the activity.
NURSESThis educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and co-provided by Global Academy for Medical Education.Continuing Nursing Education Provider Unit, Boston Uni-versity School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact Hours: 14.75Participants desiring a CNE certifi cate must complete and hand in a Claim for Credit form (indicating sessions attended) and an Evaluation form.
FACULTY DISCLOSUREBoston University School of Medicine asks all individu-als involved in the development and presentation of Continuing Medical Education (CME) activities to dis-close all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent confl icts of interest. In addition, faculty members are asked to disclose when any un-approved use of pharmaceuticals and devices is being discussed.
SPECIAL NEEDSWe encourage participation by all individuals. If you have a disability, advance notifi cation of any special needs will help us better serve you. Please email at least three weeks in advance [email protected].
Visit www.globalacademycme.com/oncology for more information and registration
Jointly sponsored/Co-provided by In affi liation with Also presented byJointly sponsored/Co-provided by In affi liation with Also presented by
PROGRAM OVERVIEWThe 7th Annual Community Oncology Conference is designed to focus on clinical and practical management issues that are a high importance to community-based oncologists and their practice teams.
Taking the “how to” approach, speakers will address specifi c therapies and their implementation in community practice, side effects and their effective manage-ment, and political and fi nancial challenges and ways to navigate them. Clinical ses-sions will provide attendees with the latest developments in treatment strategies. Case-based and interactive discussions provide perspective on what these strategies mean for the oncologist. Benefi t from expert guidance on practice manage-ment and the techniques that will help your practice thrive. Robust panel discussions on the impact of healthcare reform and controversies in patient care will engage and involve you.
Whether your practice is small, medium, or large, the 7th Annual Community Oncology Conference is a valuable resource and forum on the clinical and practical issues that matter to you and your patients. Join us March 30-31 in Las Vegas.
—Lee S. Schwartzberg, MD, FACPChair
7th Annual
Jointly sponsored/Co-provided by In affi liation with Also presented by
7th Annual
Early Bird Discount Available
7th Annual7th Annual
FEATURING
The New Alignment: Collaborative Relationships in Community Oncology
REGISTER NOW
Early Bird Discount Available
7th Annual
REGISTER NOW
Earn CME/CNE credits. Learn how to navigate oncology’s challenging clinical and practice issues.
Community Oncology Alliance
EARN 14.75
CME/CNE CREDITS
Visit www.globalacademycme.com/oncology for more information and registration
EARN 14.75 CME/CNE CREDITS
You’ll get practical and actionable information for physician leaders,nurses and administra-tors—from medicalhomes to hospital andnetwork affi liations.
Clinical & Practice Management Tracks
Clinical & Practice Management Tracks